Anovent Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

Anovent General Information


Provider of pharmaceutical products and medicines for hospitals and medical institutions. The company's products include generic and specialized inhalation medicines, enabling pharmacies and hospitals to utilize quality medicine, leading to better medical treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 8/F, Building 5
  • No. 555 Dongchuan Road, Minghang District
  • Shanghai
  • China
+86 138 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anovent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 12-Nov-2019 Completed Generating Revenue
2. Early Stage VC (Series A) 27-Jun-2019 Completed Generating Revenue
1. Seed Round 29-Sep-2018 Completed Generating Revenue
To view Anovent’s complete valuation and funding history, request access »

Anovent Executive Team (1)

Name Title Board Seat Contact Info
Hui Min He Huang Executive, Legal
To view Anovent’s complete executive team members history, request access »

Anovent Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Huatai Zijin Investment Venture Capital Minority 000 0000 000000 0
Share Capital Venture Capital Minority 000 0000 000000 0
To view Anovent’s complete investors history, request access »